163 related articles for article (PubMed ID: 11350494)
1. Comparison of IY81149 with omeprazole in rat reflux oesophagitis.
Kil BJ; Kim IW; Shin CY; Jeong JH; Jun CH; Lee SM; Kim DY; Huh IH; Sohn UD
J Auton Pharmacol; 2000; 20(5-6):291-6. PubMed ID: 11350494
[TBL] [Abstract][Full Text] [Related]
2. Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin, on experimental reflux oesophagitis in rats.
Rao CV; Vijayakumar M
Eur J Pharmacol; 2008 Jul; 589(1-3):233-8. PubMed ID: 18547560
[TBL] [Abstract][Full Text] [Related]
3. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
4. The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats.
Min YS; Yim SH; Bai KL; Choi HJ; Jeong JH; Song HJ; Park SY; Ham I; Whang WK; Sohn UD
Auton Autacoid Pharmacol; 2005 Jul; 25(3):85-91. PubMed ID: 15955027
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs.
Cao H; Wang MW; Sun LX; Ikejima T; Hu ZQ; Zhao WH
J Pharm Pharmacol; 2005 Jul; 57(7):923-7. PubMed ID: 15969954
[TBL] [Abstract][Full Text] [Related]
6. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
Armbrecht U; Abucar A; Hameeteman W; Schneider A; Stockbrügger RW
Aliment Pharmacol Ther; 1997 Oct; 11(5):959-65. PubMed ID: 9354207
[TBL] [Abstract][Full Text] [Related]
7. A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial.
Mössner J; Hölscher AH; Herz R; Schneider A
Aliment Pharmacol Ther; 1995 Jun; 9(3):321-6. PubMed ID: 7654895
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial.
Mulder CJ; Westerveld BD; Smit JM; Oudkerk Pool M; Otten MH; Tan TG; van Milligen de Wit AW; de Groot GH;
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):649-56. PubMed ID: 12072599
[TBL] [Abstract][Full Text] [Related]
9. Gastroprotective effects of pantoprazole against experimental mucosal damage.
Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
Fundam Clin Pharmacol; 2000; 14(2):89-99. PubMed ID: 10796055
[TBL] [Abstract][Full Text] [Related]
10. One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux symptoms in patients with healed reflux oesophagitis.
Mössner J; Koop H; Porst H; Wübbolding H; Schneider A; Maier C
Aliment Pharmacol Ther; 1997 Dec; 11(6):1087-92. PubMed ID: 9663834
[TBL] [Abstract][Full Text] [Related]
11. The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis.
Gardner JD; Gallo-Torres H; Sloan S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2003 Nov; 18(9):891-905. PubMed ID: 14616153
[TBL] [Abstract][Full Text] [Related]
12. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.
Corinaldesi R; Valentini M; Belaïche J; Colin R; Geldof H; Maier C
Aliment Pharmacol Ther; 1995 Dec; 9(6):667-71. PubMed ID: 8824655
[TBL] [Abstract][Full Text] [Related]
13. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
Kinoshita M; Saito N; Tamaki H
Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis.
van Rensburg CJ; Honiball PJ; Grundling HD; van Zyl JH; Spies SK; Eloff FP; Simjee AE; Segal I; Botha JF; Cariem AK; Marks IN; Theron I; Bethke TD
Aliment Pharmacol Ther; 1996 Jun; 10(3):397-401. PubMed ID: 8791969
[TBL] [Abstract][Full Text] [Related]
15. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
Nishioka K; Nagao T; Urushidani T
Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
[TBL] [Abstract][Full Text] [Related]
16. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
[TBL] [Abstract][Full Text] [Related]
17. Effects of rutin and harmaline on rat reflux oesophagitis.
Shin YK; Sohn UD; Choi MS; Kum C; Sim SS; Lee MY
Auton Autacoid Pharmacol; 2002 Feb; 22(1):47-55. PubMed ID: 12423426
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005
[TBL] [Abstract][Full Text] [Related]
19. Mucosal protective effect of leminoprazole on reflux esophagitis induced in rats.
Okabe S; Takinami Y; Iwata K; Yanagawa T
Jpn J Pharmacol; 1995 Dec; 69(4):317-23. PubMed ID: 8786634
[TBL] [Abstract][Full Text] [Related]
20. Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis.
Bardhan KD; Van Rensburg C
Aliment Pharmacol Ther; 2001 Oct; 15(10):1585-91. PubMed ID: 11563998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
